EMD Serono's agreement with the US government aims to expand IVF therapy access for 10 million women, offering significant discounts on its portfolio. The company will participate in the TrumpRx.gov platform and expand its pharmacy network, aligning with a White House Executive Order for affordable IVF access.

President Donald Trump on Thursday announced a pair of initiatives aimed at making in vitro fertilization more affordable and accessible, marking his administration’s most significant step yet on an issue that has divided conservatives and became a key point of last year’s campaign outreach to women and families.

President Trump announced a new deal that aims to give women better access to fertility treatment including In vitro fertilization.

CUTTING THROUGH RED TAPE TO DELIVER SAVINGS ON MEDICINES: President Trump also announced the FDA will be including a lower cost fertility drug in the initial round of recipients for the Commissioner’s National Priority Review Voucher program.

President Trump’s dual-pronged action on expanding access to in vitro fertilization (IVF) is garnering mixed reactions from lawmakers, advocates and medical groups, with some calling it a step in

WASHINGTON (OSV News) — President Donald Trump announced Oct. 16 a policy proposal to increase access to in vitro fertilization, including issuing guidance urging employers to offer fertility benefits directly to their employees.

President Donald Trump is expanding access to in vitro fertilization and other fertility treatments by partnering with pharmaceutical companies and expanding insurance options.

Members from the U.S. Conference of Catholic Bishops denounced President Trump's efforts to expand access to the fertility treatment.

Doctors called it “huge for patients,” if true. Patients who’ve struggled to afford the pricey medicines shared hope the price could be reached. Stocks of Novo Nordisk and Eli Lilly fell significantly.

The secretary of health and human services joined the president in the Oval Office to announce the Trump administration's goal to make in vitro fertilization more accessible to Americans by pressuring drug companies to lower the prices of fertility medication.